Our Mission

To transform the lives of patients with unmet medical needs by bringing best-in-class immune-based therapies to patients in need.

Our Pipeline

Rapidly advancing a deep portfolio of innovative therapeutics that continues to expand through our successful business development strategy.

Latest News

September 7, 2022

Zenas BioPharma Appoints Simon Lowry, M.D. as Chief Medical Officer

August 1, 2022

Zenas BioPharma Obtains IND Approval in China for Phase 1/2 Study of ZB001 for the Treatment of Thyroid Eye Disease

long-arrow-right-regularfacebook-brandsfacebook-f-brandsinstagram-brandslinkedin-brandslinkedin-in-brandssubmit-arrowtwitter-brandstwitter-square-brandsyoutube-brands